# Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

> **NCT03997370** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **NRG Oncology** · enrollment: 318 (actual)

## Conditions studied

- Malignant Solid Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **DRUG:** Carboplatin
- **DRUG:** Iohexol

## Key facts

- **NCT ID:** NCT03997370
- **Lead sponsor:** NRG Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-15
- **Primary completion:** 2027-02-06
- **Final completion:** 2028-02-06
- **Target enrollment:** 318 (ACTUAL)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03997370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03997370, "Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03997370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*